Search earnings tickers

GILD

2024Q3AMC

Gilead Sciences Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2024-11-06 · Fiscal end 2024-09-30 · Features as of 2024-11-06

← Earnings history

Street

Consensus EPS1.55

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.0%

IV front—

P/C full—

P/C front—

Features as of2024-11-06

Run-up

Close—

Ret 5d+3.9%

Ret 10d+5.1%

Ret 20d+6.4%

Ret 30d+11.5%

Print

Actual EPS

2.02Beat

Estimated EPS1.55

Actual revenue

7.5B

Surprise %+30.3%

Beat / missBeat

Beat streak 43

Beat streak 83

Reaction

1-day stock reaction+4.1%

Implied vs actual

Implied 2.0%Actual 2.5%

Gap reaction+2.5%

Day result+6.8%

Next-day upYes

Realized / IV1.26×

Post tape

Post 5d-5.9%

Post 10d-8.3%

Post volume14.4M

Vol ×10d2.30×

Vol ×20d2.72×

Post range5.1%